Datasheet Protocol

NAT8L Knockout NCI-H1703 Polyclonal Cells

Cat. No. ARG12559

Product Type:

Polyclonal Cell Population

Species:

Homo sapiens (Human)

Tissue Source:

Lung

Growth Properties:

Adherent

In stock

Request a Quote

Request Quote Ask a Question

Short Description

NAT8L Knockout NCI-H1703 Polyclonal Cells is a knockout polyclonal cell population. The NAT8L was knocked out in the NCI-H1703 cells using the CRISPR RNP technique.

Recommended Products

CRIPT Knockout HT29 Polyclonal Cells Cat. No. ARG14643

PCLAF Knockout HT29 Polyclonal Cells Cat. No. ARG14146

ARHGEF28 Knockout Hela Polyclonal Cells Cat. No. ARG20899

KAT6B Knockout MES-OV Polyclonal Cells Cat. No. ARG24695

HERC4 Knockout NCI-H1299 Polyclonal Cells Cat. No. ARG30736

DOC2A Knockout Hela Polyclonal Cells Cat. No. ARG39532

Product Details

Cell Engineering

Immortalization

Culture Conditions

Quality Control

Disclaimer

Product Details

Species:

Homo sapiens (Human)

Tissue Source:

Lung

Disease:

Squamous cell carcinoma

Morphology:

Epithelial-like

Growth Properties:

Adherent

Donor Age:

54 years

Donor Sex:

Male

Cell Engineering Information

Gene Name:

NAT8L

Gene Identifier:

NCBI Gene ID 339983

Immortalization Information

Culture Conditions

Growth medium:

RPMI 1640

Temperature:

37°C

Atmosphere:

5% CO₂

Quality Control

Sterility testing:

The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

Disclaimer

Intended Use:

This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.

Disclaimer:

Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.

Usage:

By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".